Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomic-Based Medication Safety Reviews of Persons With Intellectual and Developmental Disabilities

NCT07092852 is registered in ClinicalTrials.gov with GalenusRx, Inc. as lead sponsor.

NCT NCT07092852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07092852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomic-Based Medication Safety Reviews of Persons With Intellectual and Developmental Disabilities
Lead sponsor
GalenusRx, Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
January 31, 2028
Enrollment
700 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

developmental disability, intellectual disability, mild, intellectual disability, mild to moderate